Literature DB >> 28932522

Occult pN2 disease in lung cancer patients: a wide range of diseases endangering the long term prognosis.

Marc Riquet1, Ciprian Pricopi1, Giuseppe Mangiameli1, Alex Arame1, Alain Badia1, Françoise Le Pimpec Barthes1.   

Abstract

Entities:  

Year:  2017        PMID： 28932522      PMCID： PMC5594192          DOI： 10.21037/jtd.2017.07.23

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  [Practical issues in the surgical treatment of non-small cell lung cancer. Recommendations from the French Society of Thoracic and Cardiovascular Surgery].

Authors:  P Thomas; M Dahan; M Riquet; G Massart; P-E Falcoz; L Brouchet; F Le Pimpec Barthes; C Doddoli; E Martinod; E Fadel; H Porte Pour La Société Française De Chirurgie Thoracique Et Cardio-Vasculaire
Journal:  Rev Mal Respir       Date:  2008-10       Impact factor: 0.622

2.  Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).

Authors:  Linda W Martin; Jonathan D'Cunha; Xiaofei Wang; Debra Herzan; Lin Gu; Naif Abraham; Todd L Demmy; Frank C Detterbeck; Shawn S Groth; David H Harpole; Mark J Krasna; Kemp Kernstine; Leslie J Kohman; G Alexander Patterson; David J Sugarbaker; Robin T Vollmer; Michael A Maddaus; Robert A Kratzke
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

3.  Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.

Authors:  Elena Garelli; Stéphane Renaud; Pierre-Emmanuel Falcoz; Noëlle Weingertner; Anne Olland; Nicola Santelmo; Gilbert Massard
Journal:  Eur J Cardiothorac Surg       Date:  2016-02-25       Impact factor: 4.191

4.  Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.

Authors:  Abel Gómez-Caro; Samuel Garcia; Noemí Reguart; Pedro Arguis; Marcelo Sanchez; Josep M Gimferrer; Ramon Marrades; Francisco Lomeña
Journal:  Eur J Cardiothorac Surg       Date:  2010-01-29       Impact factor: 4.191

5.  Completeness of lung cancer surgery: is mediastinal dissection common practice?

Authors:  Ad F Verhagen; Micha C J Schoenmakers; Wout Barendregt; Hans Smit; Wim-Jan van Boven; Monica Looijen; Erik H F M van der Heijden; Henry A van Swieten
Journal:  Eur J Cardiothorac Surg       Date:  2012-01-18       Impact factor: 4.191

6.  Objective review of mediastinal lymph node examination in a lung cancer resection cohort.

Authors:  Raymond U Osarogiagbon; Jeffrey W Allen; Aamer Farooq; James T Wu
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

7.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

8.  Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer.

Authors:  K Suzuki; K Nagai; J Yoshida; M Nishimura; K Takahashi; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

9.  Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.

Authors:  Chun-Hua Dai; Jian Li; Li-Chao Yu; Xia-Qin Li; Shun-Bing Shi; Jian-Rong Wu
Journal:  Tumour Biol       Date:  2013-01-26

10.  Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.

Authors:  Mark S Allen; Gail E Darling; Taine T V Pechet; John D Mitchell; James E Herndon; Rodney J Landreneau; Richard I Inculet; David R Jones; Bryan F Meyers; David H Harpole; Joe B Putnam; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2006-03       Impact factor: 4.330
View more
  1 in total

Review 1.  Lung Cancer Treatment: From Tradition to Innovation.

Authors:  Giuseppe Mangiameli; Ugo Cioffi; Alberto Testori
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.